生物育種板塊走強 農業農村部發文支持轉基因研發
格隆匯2月19日丨生物育種板塊拉昇走強,神農科技大漲超8%,大北農漲近8%,荃銀高科漲超6%,西部牧業、隆平高科、蘇墾農發等跟漲。農業農村部辦公廳發佈關於鼓勵農業轉基因生物原始創新和規範生物材料轉移轉讓轉育的通知。通知提出,支持從事新基因、新性狀、新技術、新產品等創新性強的農業轉基因生物研發活動,積極開展農業轉基因生物生產配套性、市場成熟度、產品競爭力、技術創新性等綜合評估,遴選出能夠滿足生產需要、符合市場需求、引領未來趨勢的重大成果,打通由研發到應用的關鍵環節,加速成果推廣應用。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.